For the year ending 2025-12-31, VATE had $63,400K increase in cash & cash equivalents over the period. $146,100K in free cash flow.
| Cash Flow | 2025-12-31 |
|---|---|
| Net loss | -64,000 |
| Share-based compensation expense | 2,700 |
| Depreciation and amortization (including amounts in cost of revenue) | 30,400 |
| Amortization of deferred financing costs and debt discount | 23,700 |
| Net loss on extinguishment or repurchase of debt | -300 |
| Loss from equity investees | -5,900 |
| Gains on lease modifications | 100 |
| (gains) losses on investments | 5,200 |
| Asset impairment expense | 0 |
| Deferred income tax (benefit) expense | -100 |
| Other operating activities, net | -1,800 |
| Accounts receivable | 48,700 |
| Contract assets | -42,200 |
| Other current assets | 2,900 |
| Inventory | -4,800 |
| Other assets | -12,300 |
| Accounts payable | 57,100 |
| Accrued liabilities | 37,600 |
| Contract liabilities | 62,800 |
| Other current liabilities | -300 |
| Other liabilities | -13,700 |
| Cash provided by operating activities | 146,600 |
| Purchase of property, plant and equipment | 26,100 |
| Proceeds from disposal of property, plant and equipment | 1,400 |
| Loans to equity method investee | 0 |
| Purchase of investments | 300 |
| Proceeds from sale of investments | 2,900 |
| Cash paid for asset acquisitions | 500 |
| Other investing activities | 0 |
| Cash used in investing activities | -22,600 |
| Proceeds from rights offering and private placement, net of issuance costs | 0 |
| Proceeds from lines of credit, net of deferred financing costs | 85,900 |
| Payments on lines of credit | 116,800 |
| Proceeds from other debt obligations, net of deferred financing costs | 21,300 |
| Principal payments for and repurchases of other debt obligations | 48,700 |
| Deferred financing costs paid to third parties | 500 |
| Payments to non-controlling interests related to former sale of equity method investment | 0 |
| Dividend payments | 2,200 |
| Other financing activities | -200 |
| Cash used in financing activities | -61,200 |
| Effects of exchange rate changes on cash, cash equivalents and restricted cash | 600 |
| Net increase (decrease) in cash and cash equivalents, including restricted cash | 63,400 |
| Cash, cash equivalents and restricted cash, beginning of year | 49,300 |
| Cash, cash equivalents and restricted cash, end of year | 112,700 |
INNOVATE Corp. (VATE)
INNOVATE Corp. (VATE)